Top 10 Value Stocks to Buy Under $10
On June 16, Julian Emanuel, Chief Equity & Quantitative Strategist at Evercore, joined CNBC's 'Squawk on the Street' to discuss what's driving the markets and his bull case for the S&P 500.
Grifols Sa (GRFS)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Permian Investment Partners Alex Duran And Scott Hendrickson | 19,354,679 | $155,224,526 | +7% | 17.15% |
| 2. | Millennium Management Israel Englander | 5,005,532 | $40,144,367 | -30% | 0.02% |
| 3. | Armistice Capital Steven Boyd | 2,988,000 | $23,963,760 | +8% | 0.43% |
| 4. | Arrowstreet Capital Peter Rathjens, Bruce Clarke And John Campbell | 2,723,385 | $21,841,548 | -1% | 0.01% |
| 5. | Whitebox Advisors Andy Redleaf | 2,067,798 | $16,583,740 | -22% | 0.2% |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 592,173 | $4,192,585 | 0.12% | |
| 2. | 61,372 | $434,520 | 0.03% | |
| 3. | 47,601 | $348,915 | 0.02% | |
| 4. | 48,218 | $341,384 | 0% | |
| 5. | 34,688 | $245,592 | 0% |
News See All
Grifols, S.A. (GRFS) Sees Strong Biopharma Growth Led by Gamunex and Yimmugo
Earlier on May 7, Grifols, S.A. (NASDAQ:GRFS) reported its results for the first quarter of 2026.
11 Most Undervalued Pharma Stocks to Invest In
Haig Bathgate, CEO of Callanish Capital, stated on CNBC on May 7 that he is confident about global stocks despite worries over the Iran war.
Grifols, S.A. (NASDAQ:GRFS) Q1 2026 Earnings Call Transcript
Daniel Segarra: Hello, everyone, and thank you for joining us today for Grifols First Quarter 2026 Earnings Call.
10 Overlooked Growth Stocks to Buy Now
On April 14, Tom Lee, Fundstrat's Head of Research, joined CNBC's 'Power Lunch' to discuss his outlook on equities.
Health Canada Imposes New Conditions on Grifols, S.A. (GRFS) Plasma Collection Centers
TheFly reported on April 2 that CBC News reported that Health Canada introduced new regulatory conditions on GRFS’ paid plasma collection centers nationwide after repeated inspection failures revealed...
10 Best Healthcare Stocks to Buy and Hold for 3 Years
The first quarter of this year has seen a great deal of volatility in the equity markets. The S&P 500 fell into correction territory before rising again after first soaring to all-time highs.
Grifols, S.A. (NASDAQ:GRFS) Q3 2025 Earnings Call Transcript
Daniel Segarra: Hello, everyone. My name is Daniel Segarra, and I serve as the Head of Investor Relations and Sustainability and Vice President at Grifols.
Grifols, S.A. (GRFS) to Double Plasma Production With New Spain Facility
Grifols, S.A. (NASDAQ:GRFS) tops our list for being one of the hot stocks to buy.
7 Hot Healthcare Stocks to Buy Right Now
The majority of Americans have experienced the annoyance of having their health insurance rejected, frequently without any recourse after contacting carriers by email and phone. Dr.
Hedge Fund Resource Center